The average in-lab cost per coronary stent patient increased from $3,338 in the fourth quarter of 2001 to $4,644 in the fourth quarter of 2006, and spending on devices and drugs accounted for 98 percent of the increase. Read the full paper at HealthAffairs.org here.
This technical report was produced for the Office of the Assistant Secretary for Planning and Evaluation at the Department of Health and Human Services. The report extends and refines prior research on consumer directed health plans by incorporating the effect of prior health status on health plan choice – a necessary step for predicting health […]
This paper estimated the effects of tort law and insurer investment returns on physician malpractice insurance premiums. Data were collected on tort law from 1991 through 2004, and multivariate regression models, including fixed effects for state and year, were used to estimate the effect of changes in tort law on medical malpractice premiums. Read the […]
The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) approved tax-advantaged health savings accounts (HSAs) for certain high-deductible health insurance plans. We predict that MMA could lead to approximately 3.2 million HAS contracts among Americans ages 19–64 who are not students, not enrolled in public health insurance plans, and not eligible for group coverage […]